Operating Expenses 更改
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Almirall EUR 517.43M 265.53M 2025-06
Amarin USD 58.77M 56.06M 2025-03
Amgen USD 6.86B 85M 2025-03
argenx SE USD 744.12M 92.38M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Bayer EUR 11.41B 3.22B 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Demant DKK 9B 4.47B 2024-12
Exelixis USD 354.68M 13.9M 2025-07
Fresenius Medical Care EUR 4.55B 275.89M 2025-03
Galapagos EUR 122.32M 111.37M 2025-06
Genmab DKK 527M 3.72B 2025-03
GlaxoSmithKline GBP 5.96B 663M 2025-06
GN Store Nord DKK 3.77B 547M 2025-03
GRIFOLS EUR 1.54B 24.64M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Insmed USD 340.96M 6.11M 2025-03
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.27B 51M 2025-03
Novartis USD 9.97B 1.02B 2025-06
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 2.36B 108M 2024-12


Genmab 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.